Marcel Scheideler

Title: Marcel Scheideler: Innovator in Energy Homeostasis Treatment

Introduction

Marcel Scheideler is a notable inventor based in Graz, Austria. He has made significant contributions to the field of energy homeostasis, particularly through his innovative patent related to UCP1 (thermogenin) inducing agents. His work aims to address disorders related to energy balance, such as obesity and metabolic syndrome.

Latest Patents

Scheideler holds a patent for a composition that includes agents, such as polynucleotides, which induce or upregulate the expression of UCP1. This invention is designed for the treatment or prevention of disorders related to energy homeostasis, including overweight, adiposity, obesity, and metabolic syndrome. The patent outlines methods for administering these compositions to subjects in need of such treatments.

Career Highlights

Throughout his career, Scheideler has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Université Nice Sophia Antipolis. His experience in these organizations has contributed to his expertise in the field of metabolic research and innovation.

Collaborations

Scheideler has collaborated with notable colleagues, including Michael Karbiener and Ez-Zoubir Amri. These partnerships have likely enhanced his research and development efforts in the area of energy homeostasis.

Conclusion

Marcel Scheideler's work in developing treatments for energy homeostasis disorders showcases his innovative spirit and dedication to addressing significant health challenges. His contributions through patents and collaborations highlight the importance of research in improving metabolic health.